| |
| |
|
| Insider
Information: |
Bartizal Ken |
| Relationship: |
Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
61,376 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,376 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trius Therapeutics Inc |
TSRX |
Chief Development Offi... |
2013-09-11 |
0 |
|
0 |
Premium* |
|
|
Cidara Therapeutics, Inc. |
CDTX |
Officer |
2015-04-14 |
61,376 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CDTX |
Cidara Therapeutics, Inc. |
Chief Development OfficerOffic |
• – – |
2015-04-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
61,376 |
|
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Development Officer |
• – – |
2013-09-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(96,400) |
0 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Development Officer |
• – – |
2013-07-01 |
4 |
AS |
$8.14 |
$16,280 |
D/D |
(2,000) |
95,300 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Development Officer |
• – – |
2013-06-04 |
4 |
AS |
$7.90 |
$15,800 |
D/D |
(2,000) |
97,300 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Development Officer |
• – – |
2013-05-24 |
4 |
AS |
$7.93 |
$95,119 |
D/D |
(12,000) |
98,927 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Development Officer |
• – – |
2013-05-14 |
4 |
AS |
$7.85 |
$94,200 |
D/D |
(12,000) |
98,927 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Development Officer |
• – – |
2013-05-14 |
4/A |
S |
$7.85 |
$94,200 |
D/D |
(12,000) |
110,927 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Development Officer |
• – – |
2011-11-17 |
4 |
AS |
$7.85 |
$13,243 |
D/D |
(1,687) |
109,844 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Development OfficerOffic |
• – – |
2010-08-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
99,709 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
